Vid Mlakar, Marta Di Forti, Els F Halff, Deepak P Srivastava, Ibrahim Akkouh, Srdjan Djurovic, Carmen Martin-Ruiz, Daniel S Quintana, Viktoria Birkenæs, Nils Eiel Steen, Monica B E G Ormerod, Ole A Andreassen, Monica Aas
{"title":"Health behaviours and telomere biology in severe mental disorders.","authors":"Vid Mlakar, Marta Di Forti, Els F Halff, Deepak P Srivastava, Ibrahim Akkouh, Srdjan Djurovic, Carmen Martin-Ruiz, Daniel S Quintana, Viktoria Birkenæs, Nils Eiel Steen, Monica B E G Ormerod, Ole A Andreassen, Monica Aas","doi":"10.1038/s41398-026-04362-2","DOIUrl":null,"url":null,"abstract":"<p><p>Alterations in telomere length (TL), a marker of cellular ageing, have been reported in individuals with severe mental disorders (SMD). Epidemiological studies of the general population have highlighted that unhealthy lifestyles may exacerbate telomere attrition. However, the impact of lifestyle on TL within the context of SMD remains unexplored. The study consisted of 410 participants (schizophrenia spectrum [n = 225] and affective disorder [n = 185]) collected as part of the Norwegian Thematically Organised Psychosis (TOP) study. Leukocyte TL was measured via blood and determined by quantitative real-time Polymerase Chain Reaction (qPCR). Patients provided self-report data on six lifestyle domains including: diet, exercise, smoking, alcohol consumption, substance use, and coffee consumption. A global dichotomised (healthy vs unhealthy) lifestyle variable was created, as well as a health behaviour variable, indicating the level of unhealthy behaviours. Individuals with an unhealthy lifestyle had shorter TL compared to those with a healthy lifestyle (Cohen's d = 0.58, F = 8.62, p = 0.004). A relationship was observed between increasing number of unhealthy behaviours and shorter TL (F = 2.69, p = 0.02), adjusted for age, sex, ethnicity, trauma exposure, medication daily defined dose (DDD), years of education and diagnosis. In terms of base-pair loss, individuals with healthy lifestyles exhibited a roughly 6-year lower biological age, compared to individuals with unhealthy lifestyles. Our study indicates that a healthier lifestyle is associated with longer TL in SMD. This highlights the importance of health behaviours as potential clinical targets for ensuring healthier cellular ageing in psychiatric populations.</p>","PeriodicalId":23278,"journal":{"name":"Translational Psychiatry","volume":"16 1","pages":""},"PeriodicalIF":7.5000,"publicationDate":"2026-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13550598/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41398-026-04362-2","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
Abstract
Alterations in telomere length (TL), a marker of cellular ageing, have been reported in individuals with severe mental disorders (SMD). Epidemiological studies of the general population have highlighted that unhealthy lifestyles may exacerbate telomere attrition. However, the impact of lifestyle on TL within the context of SMD remains unexplored. The study consisted of 410 participants (schizophrenia spectrum [n = 225] and affective disorder [n = 185]) collected as part of the Norwegian Thematically Organised Psychosis (TOP) study. Leukocyte TL was measured via blood and determined by quantitative real-time Polymerase Chain Reaction (qPCR). Patients provided self-report data on six lifestyle domains including: diet, exercise, smoking, alcohol consumption, substance use, and coffee consumption. A global dichotomised (healthy vs unhealthy) lifestyle variable was created, as well as a health behaviour variable, indicating the level of unhealthy behaviours. Individuals with an unhealthy lifestyle had shorter TL compared to those with a healthy lifestyle (Cohen's d = 0.58, F = 8.62, p = 0.004). A relationship was observed between increasing number of unhealthy behaviours and shorter TL (F = 2.69, p = 0.02), adjusted for age, sex, ethnicity, trauma exposure, medication daily defined dose (DDD), years of education and diagnosis. In terms of base-pair loss, individuals with healthy lifestyles exhibited a roughly 6-year lower biological age, compared to individuals with unhealthy lifestyles. Our study indicates that a healthier lifestyle is associated with longer TL in SMD. This highlights the importance of health behaviours as potential clinical targets for ensuring healthier cellular ageing in psychiatric populations.
端粒长度(TL)的改变是细胞衰老的标志,在严重精神障碍(SMD)患者中有报道。对普通人群的流行病学研究强调,不健康的生活方式可能加剧端粒磨损。然而,在SMD的背景下,生活方式对TL的影响仍未被探索。该研究包括410名参与者(精神分裂症谱系[n = 225]和情感障碍[n = 185]),作为挪威主题组织精神病(TOP)研究的一部分收集。血液检测白细胞TL,实时荧光定量pcr (qPCR)测定。患者提供了六个生活方式领域的自我报告数据,包括:饮食、运动、吸烟、饮酒、物质使用和咖啡消费。创建了一个全球二分(健康与不健康)生活方式变量,以及一个健康行为变量,表明不健康行为的水平。生活方式不健康的人比生活方式健康的人TL短(Cohen’s d = 0.58, F = 8.62, p = 0.004)。在年龄、性别、种族、创伤暴露、每日限定剂量(DDD)、受教育年限和诊断等因素调整后,观察到不健康行为数量增加与较短的生存期之间存在关系(F = 2.69, p = 0.02)。就碱基对丧失而言,生活方式健康的个体比生活方式不健康的个体表现出大约低6岁的生物年龄。我们的研究表明,健康的生活方式与SMD患者较长的生存期有关。这突出了健康行为作为确保精神科人群更健康的细胞衰老的潜在临床目标的重要性。
期刊介绍:
Psychiatry has suffered tremendously by the limited translational pipeline. Nobel laureate Julius Axelrod''s discovery in 1961 of monoamine reuptake by pre-synaptic neurons still forms the basis of contemporary antidepressant treatment. There is a grievous gap between the explosion of knowledge in neuroscience and conceptually novel treatments for our patients. Translational Psychiatry bridges this gap by fostering and highlighting the pathway from discovery to clinical applications, healthcare and global health. We view translation broadly as the full spectrum of work that marks the pathway from discovery to global health, inclusive. The steps of translation that are within the scope of Translational Psychiatry include (i) fundamental discovery, (ii) bench to bedside, (iii) bedside to clinical applications (clinical trials), (iv) translation to policy and health care guidelines, (v) assessment of health policy and usage, and (vi) global health. All areas of medical research, including — but not restricted to — molecular biology, genetics, pharmacology, imaging and epidemiology are welcome as they contribute to enhance the field of translational psychiatry.